AWS Partners
-- 2003 AKC Canine Health Foundation Conference -- Cardiology Update
AWS Partners Home
Quick Glance at Recent Updates
News Flash!
History, Mission, and Accomplishments
The Keoni Project - Epilepsy in the American Water Spaniel
Seizure Pictures
Donations
Education: Health Topics & Links
Photo Album of our AWS Partners
AWS Memorial
Contact Us

Kathryn Meurs, DVM,PhD; Ohio State University

 

 

The Genetic Evaluation of Dilated Cardiomyopathy in the Doberman Pinscher:

 

Dilated cardiomyopathy (DCM), a primary heart muscle disorder characterized by poor cardiac function, is inherited in the Doberman Pinscher.  Therapy for DCM does not cure or even successfully control the clinical signs.  The inability to control the disease has led to increased interest in disease prevention through careful selection of unaffected dogs for breeding.  However, since DCM is often not apparent until later in the adult life of the dog, many dogs are selected for breeding before they are found to be affected.  A blood test that could identify affected animals before they are used for breeding would greatly decrease the prevalence of DCM.

 

Careful evalulation of a 4 generation, 39 member family has provided an explanation of the pattern of inheritance of the disease.  A genome wide scan is being performed to identify informative canine markers associated with DCM in the Doberman Pinscher.  Genetic markers from the canine genetic map are evaluated by polymerase chain reaction (PCR) and linkage analysis and evaluated for genetic linkage with MLINK.  The highest linkage score we have identified so far is 1.9.  A canine marker with a score of 3 or greater is considered a significant lead in the identification of the genetic cause of this disease.

 

The Genetic Evaluation of Canine Subvalvular Aortic Stenosis:

 

Subvalvular Aortic Stenosis (SAS) is a congenital heart disease characterized by a fibrous ridge located below the aortic valve.  Affected dogs are at risk of developing heart valve infections, congestive heart failure or sudden death.  Although mildly affected dogs can live a normal lifespan, severely affected dogs live an average of 19 months.  The defect has been shown to be inherited in the Newfoundland breed, and is likely to be inherited in the Golden Retriever, Boxer and Rottweiler, among others.  Since this is a familial defect in at least some breeds, affected dogs should not be bred.  However, mildly affected dogs can be difficult to diagnose without Doppler echocardiography, an expensive test with limited availability.  Therefore, there is significant interest in developing a blood test to screen for SAS. 

 

The objectives of the studies are to define the clinical (phenotypic) and genotypic characteristics of SAS in various breeds of dogs.  A genome wide scan is being performed to identify informative canine markers associated with SAS in individual breeds of dogs.  In the Newfoundland, 3 close families of dogs are being studied to identify a genetic marker linked to SAS.  Genetic markers from the canine genetic map are evaluated by polymerase chain reaction (PCR) and linkage analysis and evaluated for genetic linkage with MLINK.  This will be the first step in the development of a DNA screening test for this disease.

 

  

Steps to Correct Cardiac Concerns in Your Breed

 

Stage I

 

1.           Characterize your breed’s heart disease

 

a.    Collect solid, specific information about clinical and familial aspects of disease in veterinary literature.

b.    Use caution when interpreting clinical or genetic data from one breed to another.

 

2.            Participate in clinical studies to determine specific aspects of a disease

 

a.    Determine whether disease is congenital vs. adult onset acquired

b.    Evaluate as many dogs as possible and re-evaluate annually for change, to maintain current status for acquired defects

c.    Apply retrospective research: investigate records already on file

d.    Apply prospective research: recruit current information on affected dogs

e.    Determine what is normal

1.    50 normal dogs at age of onset are used as a baseline

2.    3 generations are used to check pedigrees to evaluate familial tendencies, using all normal and affected dogs

 

Pros and cons to consider:

Retrospective research is inexpensive; prospective research is accurate but expensive.  There is immediate impact in developing screening programs since they help to positively identify clinical aspect.

 

Stage II

 

1.    Characterize familial aspects

 

a.     Evaluate pedigrees for mode of inheritance.

b.     Perform repeated testing to maintain current status for acquired defects.

c.     Evaluate male/female results that could determine if a sex link is involved.

 Stage III

 

1.     Characterize molecular aspects of familial heart disease.

a.     This process can take up to 30 years to evaluate continuing generations.

b.     Compare and search for studies in humans.  Human studies often use the dog as a model, which could allow for possible funding.

 

 

Conclusive summary:

 

Determine what is normal.

Survey specific info: age of onset, clinical manifestations, life span, determine other conditions present.

Test annually to determine new onset or evaluate changes.

Conduct pedigree analysis to determine mode of inheritance.

Characterize molecular aspects.

Compare and search for studies in humans to propose using dog as model; look for possible funding.

 

AWS Partners’ recommended resources:

 

Canine Dilated Cardiomyopathy – Recognition and Clinical Management

http://www.vin.com/proceedings/Proceedings.plx?CID=WALTHAMOSU2002&PID=2981

 

Canine Cardiomyopathy and Heart Failure

http://www.pethealthcare.net/html/body_canine_dilated_cardiomyopathy_.html

 

“The more we learn, the less we know”: A Progress Report to the ABC Membership

http://www.boxerunderground.com/bu2000/abc2001/drmeurs01.htm

 

Familial Ventricular Arrhythmia in Boxers

http://www.boxerclubofarizona.org/meursfva.htm

 

Hypomagnesemia and Mitral Valve Prolapse in Cavalier King Charles Spaniels

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9923143&dopt=Abstract

 

Mitral Valve Disease in Cavalier King Charles Spaniels

http://home.vicnet.net.au/~cavalier/mitral.htm

 

Cavalier Health Foundation Grants

http://www.cavalierhealthfoundation.com/grants.htm

 

Mitral Valve Prolapse: What Causes It?  What Diet Changes Can Help?

http://www.ctds.info.mvp1.html

 

VetCentric: Dilated Cardiomyopathy

http://www.vetcentric.com/reference/encycEntry.cfm?ENTRY=76&COLLECTION=EncycIllness&MODE=full

 

Diary of Chronic Valvular Disease

http://www.wtv-zone.com/Marvaline/KD/canineheart.html

 

Cardiac Heart Disease (Pedigree)

http://www.pedigreebreeder.com.au/features/nutrition/default.asp?s=6

 

Mitral Valve Disease

http://www.rhiannon-cavaliers.com/mvd.htm

 

Canine Cardiology

http://www.usask.ca/wcvm/canine

 

Clinical Cardiology Concepts in the Dog and Cat

http://www.vetgo.com/cardio/concepts/concsect.php?ques

 

awspartners@earthlink.net

   

 

AWS PARTNERS

Achieving Wellness Solutions in the American Water Spaniel

 

Last updated on

     

Dogwise.com All Things Dog!